Security key
G6724L116
OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO)
CUSIP: G6724L116
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary Shares, no par value
- Shares outstanding
- 52,174,143
- Total 13F shares
- 2,770,797
- Share change
- +695,715
- Total reported value
- $1,479,794
- Price per share
- $2.57
- Number of holders
- 5
- Value change
- +$329,427
- Number of buys
- 3
- Number of sells
- 4
Report period
Q2 2025
Institutions
5
Top holders
5
OKYO full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
OKYO Pharma Ltd SEC filings
OKYO Pharma Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP G6724L116
Recent filing periods:
Top shareholders of OKYO - OKYO Pharma Ltd - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Dauntless Investment Group, LLC |
13F
|
Company |
3.8%
|
1,988,780
|
$2,525,751 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
27,404
|
$34,803 | — | 31 Mar 2025 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.04%
|
20,000
|
$25,000 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
13,946
|
$17,711 | — | 31 Mar 2025 | |
| Cerity Partners LLC |
13F
|
Company |
0.02%
|
12,812
|
$16,271 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
12,090
|
$15,354 | — | 31 Mar 2025 | |
| Continuum Advisory, LLC |
13F
|
Company |
0%
|
50
|
$64 | — | 31 Mar 2025 | |
| John P. Brancaccio |
3/4/5
|
Director |
—
class O/S missing
|
16,670
|
$25,005 | — | 15 Sep 2023 |
Institutional Holders of OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO) as of Q2 2025
As of 30 Jun 2025,
OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,770,797 shares.
The largest 5 holders included
Dauntless Investment Group, LLC, Cerity Partners LLC, GEODE CAPITAL MANAGEMENT, LLC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, and UBS Group AG.
This page lists
5
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
7
Q2 2025 holders
5
Holder diff
-2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.